We are live on ! Find out more
CCA

Catalyst Capital Advisors Portfolio holdings

AUM $6.03B
1-Year Est. Return 24.5%
This Fund
S&P 500
This Quarter Est. Return
+14.93%
1 Year Est. Return
+24.5%
3 Year Est. Return
+62.66%
5 Year Est. Return
+62.45%
10 Year Est. Return
+241.55%
AUM
$2.87B
AUM Growth
+$187M
Cap. Flow
-$176M
Cap. Flow %
-6.14%
Top 10 Hldgs %
64.21%
Holding
508
New
96
Increased
109
Reduced
110
Closed
117

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$17.3M
2
A icon
Agilent Technologies
A
+$12.8M
3
WOLF icon
Wolfspeed
WOLF
+$11.1M
4
SPR
Spirit AeroSystems
SPR
+$8.74M
5
PG icon
Procter & Gamble
PG
+$7.3M

Top Sells

Rank Stock Value
1
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$32.4M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$27.8M
3
AMGN icon
Amgen
AMGN
+$22.1M
4
VB icon
Vanguard Small-Cap ETF
VB
+$18.3M
5
AXP icon
American Express
AXP
+$16.2M

Sector Composition

Rank Sector Weight
1 Energy 7.81%
2 Technology 4.09%
3 Healthcare 3.02%
4 Industrials 2.34%
5 Consumer Discretionary 2.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FUTU icon
301
Futu Holdings
FUTU
$13.9B
$10K ﹤0.01%
+560
New +$9.7K
HUBS icon
302
HubSpot
HUBS
$10.5B
$10K ﹤0.01%
59
+5
+9% +$792
STNE icon
303
StoneCo
STNE
$2.62B
$10K ﹤0.01%
250
– –
TME icon
304
Tencent Music
TME
$14.5B
$10K ﹤0.01%
540
– –
YMAB
305
DELISTED
Y-mAbs Therapeutics
YMAB
$10K ﹤0.01%
400
-100
-20% -$2.2K
DAY
306
DELISTED
Dayforce
DAY
$10K ﹤0.01%
+200
New +$8.84K
GMDA
307
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$10K ﹤0.01%
850
– –
HEI icon
308
HEICO Corp
HEI
$48.9B
$9K ﹤0.01%
100
-200
-67% -$17.4K
TWST icon
309
Twist Bioscience
TWST
$5.62B
$9K ﹤0.01%
400
-100
-20% -$2.26K
SWAV
310
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$9K ﹤0.01%
+280
New +$9.3K
VAPO
311
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$9K ﹤0.01%
56
– –
THOR
312
DELISTED
Synthorx, Inc. Common Stock
THOR
$9K ﹤0.01%
465
– –
ESTC icon
313
Elastic
ESTC
$6.1B
$8K ﹤0.01%
100
– –
GOSS icon
314
Gossamer Bio
GOSS
$66.5M
$8K ﹤0.01%
+350
New +$7.3K
PDD icon
315
Pinduoduo
PDD
$118B
$8K ﹤0.01%
325
– –
AYX
316
DELISTED
Alteryx Inc
AYX
$8K ﹤0.01%
97
– –
ARCE
317
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$8K ﹤0.01%
250
– –
TCRR
318
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$8K ﹤0.01%
+459
New +$8.14K
SWI
319
DELISTED
SolarWinds Corporation Common Stock
SWI
$8K ﹤0.01%
403
-24
-6% -$450
VSM
320
DELISTED
Versum Materials, Inc.
VSM
$8K ﹤0.01%
156
+10
+7% +$398
ALEC icon
321
Alector
ALEC
$164M
$7K ﹤0.01%
+350
New +$6.62K
CARG icon
322
CarGurus
CARG
$3.01B
$7K ﹤0.01%
164
+45
+38% +$1.76K
COLD icon
323
Americold
COLD
$4.09B
$7K ﹤0.01%
217
-165
-43% -$4.75K
DAVA icon
324
Endava
DAVA
$141M
$7K ﹤0.01%
238
– –
GH icon
325
Guardant Health
GH
$19.5B
$7K ﹤0.01%
91
-15
-14% -$832
11 12
13
14 15

Similar funds

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
GA
Greenhaven Associates Purchase, New York $6.07B AUM 11.2% 1-Year Est. Return

Catalyst Capital Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Catalyst Capital Advisors held 508 positions worth $2.87B, up 7% from $2.68B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Catalyst Capital Advisors withdrew a net $176M in Q1 2019, closing 117 positions and reducing 110 holdings. Its most notable exit was Amgen, an estimated $22.1M position sold in full.

By sector, the portfolio is most concentrated in Energy at 7.8% of assets, up from 6.1% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Catalyst Capital Advisors opened a new position in Aflac worth $18M.

  • Catalyst Capital Advisors's largest Q1 2019 buy was Aflac: 360,000 shares worth $18M.
  • Catalyst Capital Advisors added most to Agilent Technologies in Q1 2019, an estimated $12.8M increase.
  • Catalyst Capital Advisors's biggest Q1 2019 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $32.4M.
  • Catalyst Capital Advisors fully exited Amgen in Q1 2019, selling an estimated $22.1M.
  • Catalyst Capital Advisors's ten largest holdings make up 64% of its $2.87B portfolio in Q1 2019.
  • Catalyst Capital Advisors opened 96 new positions and closed 117 in Q1 2019.
  • Catalyst Capital Advisors's portfolio value rose 7% quarter-over-quarter to $2.87B.

Based on Catalyst Capital Advisors's 13F filing for Q1 2019, filed 8 May 2019.